International Society For Pharmaceutical Engineering Launches GAMP(R) 5 Technical Document

Main Category: Pharma Industry / Biotech Industry
Article Date: 05 Mar 2008 - 3:00 PDT

email to a friend   printer friendly   opinions  

ISPE (International Society for Pharmaceutical Engineering), a global not-for-profit association of 25,000 pharmaceutical manufacturing professionals, has issued the global launch of GAMP® 5: A Risk-Based Approach to Compliant GXP Computerized Systems, its latest industry-impacting technical publication.

The document is the fifth revision of the original document published in 1994. In this major upgrade, GAMP® 5 addresses the entire lifecycle of a computerized system, and the principles are applicable to a wide range of information systems, lab equipment, integrated manufacturing systems, and IT infrastructure.

"GAMP 5 is a major revision of the last version released in 2001 and is aimed at enabling innovation and pragmatic, cost-effective compliance," said Sion Wyn, Editor of the Guide, and member of the ISPE GAMP Community of Practice Council. "It describes a common-sense approach based on current good practice."

The document was developed by users within the field, according to Wyn. "We have an established community of expert practitioners from all over the world who have been working in this area for many years. It has the strength of the community behind it."

This technical document provides pragmatic and practical industry guidance that aims to achieve compliant computerized systems that are fit for intended use in an efficient and effective manner while also enabling innovation and technological advance.

This document describes a flexible risk-based approach to compliant GxP regulated computerized systems, based on scalable specification and verification. A robust quality risk management process based on ICH Q9 principles is central to the approach.

GAMP® 5 also contains new information on topics including outsourcing, electronic batch recording, end user applications (such as spreadsheets and small database applications), and patch management.

As with all ISPE technical documents, the document utilizes a practical, pragmatic, non-theoretical approach, giving the reader guidance on solving problems, and is a valuable tool when it comes to regulatory inspections, directly assisting in compliance issues.

GAMP® 5 will be introduced at ISPE's Conference on Manufacturing Excellence, 25-28 February 2008 in Tampa, Florida, USA. A complimentary copy of GAMP® 5 will be provided to conference delegates attending the session, GAMP 5: Enabling Innovation and Technological Advance. To register or to find out more information, please visit http://www.ISPE.org/manufacturingexcellence.

The European launch of GAMP® 5 will take place at ISPE's Congress on Innovation in Copenhagen, Denmark, April 2008. To register or find out more information, please visit http://www.ISPE.org/CopenhagenCongress.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical manufacturing professionals in 90 countries around the globe. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; and its Asia Pacific office in Singapore. Visit http://www.ISPE.org for additional Society news and information.

International Society for Pharmaceutical Engineering

• Additional
• References
• Citations